Octapharma AB
PolandAll drugs from this manufacturer
-
The medicine is used to treat congenital and acquired antithrombin deficiency. It helps to prevent the formation of deep vein thrombosis and embolisms, especially in high-risk situations such as childbirth or surgical procedures.
Dosage form: powder and solvent for preparation of infusion solution
Active substance Dosage human antithrombin iii 50 j.m./1 ml ATC: B01AB02
-
The medicine is used for the treatment and prevention of bleeding in people with hemophilia A, which results from a congenital deficiency of coagulation factor VIII in the blood.
Dosage form: solution for injection, powder and solvent for preparation of
Active substance Dosage human coagulation factor viii 100 j.m./ml ATC: B02BD02
-
It is a medicinal product containing human coagulation factor VIII, which is supplied as a powder for solution for injection.
Dosage form: solution for injection, powder and solvent for preparation of
Active substance Dosage human coagulation factor viii 200 j.m./ml ATC: B02BD02
-
It is used to treat complex coagulation factor deficiencies that may result from acute liver failure or massive transfusion. It may also be administered in emergency situations to rapidly reverse the effects of anticoagulants or to restore coagulation factor balance during plasma exchange.
Dosage form: solution for infusion
Active substance Dosage human plasma protein 9-14 g/200 ml ATC: B05AA
-
The medicine is used in women with Rh-negative blood group to prevent the production of antibodies that could harm the unborn baby (especially in subsequent pregnancies). It is administered, among other things, after the birth of an Rh-positive child, in cases of miscarriage, ectopic pregnancy, or after certain medical procedures during pregnancy.
Dosage form: solution for injection
Active substance Dosage human anti-d immunoglobulin 750 IU/ml ATC: J06BB01